These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 26973120)

  • 1. Cancer vaccines for hepatocellular carcinoma: future directions.
    Buonaguro FM; Buonaguro L
    Immunotherapy; 2016; 8(4):391-3. PubMed ID: 26973120
    [No Abstract]   [Full Text] [Related]  

  • 2. Challenges in cancer vaccine development for hepatocellular carcinoma.
    Buonaguro L; Petrizzo A; Tagliamonte M; Tornesello ML; Buonaguro FM
    J Hepatol; 2013 Oct; 59(4):897-903. PubMed ID: 23714157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell-associated immunotherapy: a promising strategy for the treatment of hepatocellular carcinoma.
    Ma W; Chen X; Yuan Y
    Immunotherapy; 2017 Jun; 9(7):523-525. PubMed ID: 28595519
    [No Abstract]   [Full Text] [Related]  

  • 4. [What are the limits of efficacy for immunotherapy against hepatocellular carcinoma and its clinical availability].
    Jia D; Wang H; Wu J
    Zhonghua Gan Zang Bing Za Zhi; 2014 May; 22(5):393-6. PubMed ID: 25184317
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeting Tumor-Associated Antigens in Hepatocellular Carcinoma for Immunotherapy: Past Pitfalls and Future Strategies.
    Lu L; Jiang J; Zhan M; Zhang H; Wang QT; Sun SN; Guo XK; Yin H; Wei Y; Li SY; Liu JO; Li Y; He YW
    Hepatology; 2021 Feb; 73(2):821-832. PubMed ID: 32767586
    [No Abstract]   [Full Text] [Related]  

  • 6. Potential of immunotherapy for hepatocellular carcinoma.
    Breous E; Thimme R
    J Hepatol; 2011 Apr; 54(4):830-4. PubMed ID: 21145836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy for hepatocellular carcinoma.
    Li S; Yang F; Ren X
    Drug Discov Ther; 2015 Oct; 9(5):363-71. PubMed ID: 26632545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunobiology and gene-based immunotherapy of hepatocellular carcinoma.
    Geissler M; Mohr L; Ali MY; Grimm CF; Ritter M; Blum HE
    Z Gastroenterol; 2003 Nov; 41(11):1101-10. PubMed ID: 14648380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous and therapeutic immune responses in hepatocellular carcinoma: implications for current and future immunotherapies.
    Wirth TC
    Expert Rev Gastroenterol Hepatol; 2014 Jan; 8(1):101-10. PubMed ID: 24410473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations.
    Xie Y; Xiang Y; Sheng J; Zhang D; Yao X; Yang Y; Zhang X
    J Immunol Res; 2018; 2018():8740976. PubMed ID: 29785403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy.
    Schmidt N; Neumann-Haefelin C; Thimme R
    Dig Dis; 2012; 30(5):483-91. PubMed ID: 23108304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tackling hepatocellular carcinoma with individual or combinatorial immunotherapy approaches.
    Tagliamonte M; Mauriello A; Cavalluzzo B; Ragone C; Manolio C; Petrizzo A; Buonaguro L
    Cancer Lett; 2020 Mar; 473():25-32. PubMed ID: 31875523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of cancer-testis antigens in immunotherapy of hepatocellular carcinoma.
    Seifi-Alan M; Shamsi R; Ghafouri-Fard S
    Immunotherapy; 2018 Apr; 10(5):411-421. PubMed ID: 29473472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy in hepatocellular carcinoma.
    Buonaguro L; Mauriello A; Cavalluzzo B; Petrizzo A; Tagliamonte M
    Ann Hepatol; 2019; 18(2):291-297. PubMed ID: 31047849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives of immunotherapy in hepatocellular carcinoma (HCC).
    Büttner N; Schmidt N; Thimme R
    Z Gastroenterol; 2016 Dec; 54(12):1334-1342. PubMed ID: 27936483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for successful vaccination against hepatocellular carcinoma.
    Rinaldi M; Iurescia S; Fioretti D; Ponzetto A; Carloni G
    Int J Immunopathol Pharmacol; 2009; 22(2):269-77. PubMed ID: 19505380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of immunotherapy as a novel way to treat hepatocellular carcinoma.
    Mukaida N; Nakamoto Y
    World J Gastroenterol; 2018 May; 24(17):1839-1858. PubMed ID: 29740200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune-based therapies for hepatocellular carcinoma.
    Pinato DJ; Guerra N; Fessas P; Murphy R; Mineo T; Mauri FA; Mukherjee SK; Thursz M; Wong CN; Sharma R; Rimassa L
    Oncogene; 2020 Apr; 39(18):3620-3637. PubMed ID: 32157213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immune therapy against hepatocellular carcinoma using gene-modified tumor cells].
    Miyagi T; Tatsumi T; Hayashi N
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():688-92. PubMed ID: 11762038
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunotherapy for hepatocellular carcinoma using dendritic cells].
    Homma S; Toda G; Ohno T
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():693-8. PubMed ID: 11762039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.